For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Neurosigma, Inc.

USPTO Granted Patents = 10

% Expired Patents = 10.0

CIPO Patents = 1

EPO Patents = 5

Trademarks = 5

Forward Citations = 196

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Ian A Cook (6 out of 25 patents)

Leon Ekchian (6 out of 10 patents)

Christopher M DeGiorgio (5 out of 16 patents)

4. Colin Kealey (4 out of 18 patents)

5. Patrick R Miller (4 out of 14 patents)

6. Alejandro Covalin (1 out of 28 patents)

7. Antonio A F Desalles (1 out of 1 patent)

8. Alessandra Gorgulho (1 out of 1 patent)

9. Antonio Afonso Ferreira De Salles (1 out of 1 patent)

10. Christopher M Degiorgio (3 patents)

11. Antonio Desalles (0 patent)

12. Patrick Miller (0 patent)

13. Antonio Desalles (0 patent)

14. Patrick Miller (0 patent)

15. Antonio AF Desalles (0 patent)

10 patents: Sort by Forward Citations

1. 10537729 - Trigeminal neurostimulation based upon pulse counting and chronobiology (2020-01-21),

2. 10525254 - Cutaneous electrode (2020-01-07),

3. 10195435 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2019-02-05),

4. 10035013 - Subcutaneous electrodes for cranial nerve stimulation (2018-07-31),

5. 10016601 - Pulse generator for cranial nerve stimulation (2018-07-10),

6. 9731127 - Modulation of autonomic nervous system activity and integrated electrode assemblies for trigeminal neurostimulation (2017-08-15),

7. 9675794 - Cutaneous electrode (2017-06-13),

8. 9511223 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2016-12-06),

9. 8958880 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2015-02-17),

10. 8257684 - Methods for identifying and targeting autonomic brain regions (2012-09-04),

Neurosigma, Inc. is a medical technology company focused on developing non-invasive neuromodulation therapies for neurological and neuropsychiatric disorders. Their flagship product, the Monarch eTNS System, is FDA cleared for the treatment of ADHD and is also being studied for other conditions such as epilepsy and depression.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#198 in Los Angeles, CA

#7,106 in California

#29,828 in US

#55,954 in the World

Los Angeles, CA, United States of America

Neurosigma, Inc.

Forward Citations = 196

9 inventors:

Ian A Cook (6 out of 25 patents)

Leon Ekchian (6 out of 10 patents)

Christopher M DeGiorgio (5 out of 16 patents)

4. Colin Kealey (4 out of 18 patents)

5. Patrick R Miller (4 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…